Ashburn D, Joss A W, Pennington T H, Ho-Yen D O
Microbiology Department, Raigmore Hospital, Inverness.
J Clin Pathol. 1995 Jan;48(1):64-9. doi: 10.1136/jcp.48.1.64.
To develop an immunosorbent agglutination assay for the detection of Toxoplasma gondii IgE antibodies (IgE-ISAGA); to assess its specificity; and to determine the role of specific IgE in the diagnosis of current toxoplasma infection.
Rabbit antihuman IgE capture antibody was adsorbed onto microtitre plates and formaldehyde fixed tachyzoites were used to identify specific antibody. Specificity was assessed in 513 serum samples (blood donor, potentially interfering and difficult, elevated and low total IgE and myeloma). Serum samples (n = 108) from 65 patients with documented toxoplasmosis were tested, as were 26 serum samples from nine pregnant women positive for specific IgM and 30 from 20 HIV positive patients.
IgE-ISAGA was highly specific with only three of 513 (0.58%) positive reactions amongst the control groups, one of which (0.19%) was regarded as a false positive. Elevated total IgE did not influence specific IgE results nor did the presence of abnormal immunoglobulin concentrations. Sixty (92.3%) patients with toxoplasma associated lymphadenopathy had specific IgE in one or more samples. Positive or borderline results were obtained in 68 of 77 (88.3%) serum samples taken up to four months after onset and were also detected for up to 11 months in 21 of 31 (67.7%) sera. Of the nine pregnant women with detectable specific IgM, specific IgE was absent in five (12 specimens). Specific IgE was also detected in 10 of 30 (33.3%) serum samples from the 20 HIV positive patients, which was similar to the number with specific IgM. Neither the specific IgE nor IgM tests could distinguish symptomatic from asymptomatic HIV positive patients.
IgE-ISAGA is sensitive, specific, and easy to perform. Although results suggest that specific IgE may be less helpful than previously claimed, specific IgE has a useful role in the diagnosis of current toxoplasma infection when used in conjunction with other tests.
开发一种用于检测弓形虫IgE抗体的免疫吸附凝集试验(IgE-ISAGA);评估其特异性;并确定特异性IgE在当前弓形虫感染诊断中的作用。
将兔抗人IgE捕获抗体吸附到微量滴定板上,并用甲醛固定的速殖子来鉴定特异性抗体。在513份血清样本(献血者、潜在干扰和疑难样本、总IgE升高和降低以及骨髓瘤样本)中评估特异性。检测了65例有弓形虫病记录患者的血清样本(n = 108),以及9例特异性IgM阳性孕妇的26份血清样本和20例HIV阳性患者的30份血清样本。
IgE-ISAGA具有高度特异性,在对照组的513份样本中只有3份(0.58%)呈阳性反应,其中1份(0.19%)被视为假阳性。总IgE升高不影响特异性IgE结果,异常免疫球蛋白浓度的存在也不影响。60例(92.3%)弓形虫相关性淋巴结病患者的一个或多个样本中有特异性IgE。在发病后4个月内采集的77份血清样本中有68份(88.3%)获得阳性或临界结果,在31份血清中的21份(67.7%)中也检测到长达11个月。在9例可检测到特异性IgM的孕妇中,5例(12份样本)没有特异性IgE。在20例HIV阳性患者的30份血清样本中有10份(33.3%)检测到特异性IgE,这与特异性IgM阳性的数量相似。特异性IgE和IgM检测均无法区分有症状和无症状的HIV阳性患者。
IgE-ISAGA敏感、特异且易于操作。尽管结果表明特异性IgE可能不如先前声称的那么有用,但特异性IgE与其他检测方法联合使用时,在当前弓形虫感染的诊断中具有有用的作用。